UBIGENE

ZCCHC12 Knockout cell line (HEK293-A)

banner

Red cotton OmniCell bank

10000+
Gene Knockout Cell Lines
2000+
Luc/EGFP/Cas9 Tool Cell Lines
1000+
Wild-type Cell Lines
ZCCHC12 Knockout cell line (HEK293-A)
Copy Product Info
Catalog#
YKO-HA240305
Species
Human
Target Cell Line
HEK293-A
Size
1*10^6
Gene
ZCCHC12
Storage conditions
Shipped on dry ice; Store in liquid nitrogen

Overview

Gene knockout cell lines are generated using CRISPR-Cas9 based technology to precisely disrupt target genes, enabling functional genomics research, disease modeling, and target validation.

ZDHHC11B (zDHHC palmitoyltransferase 11B, putative) encodes a protein predicted to possess protein-cysteine S-palmitoyltransferase activity. It is predicted to participate in protein palmitoylation and antiviral innate immune responses and to promote host defense against viral infection. ZDHHC11B is predicted to localize to endosomal membranes and to function in the Golgi apparatus and endoplasmic reticulum, suggesting a role in membrane-associated regulation of protein signaling and trafficking.

Before delivery, each clone is authenticated by STR, tested for sterility and mycoplasma, and genotype‑verified by two‑round PCR‑sequencing. Comprehensive QC data accompany every shipment to support reproducible research.

KO Cell Construction Strategy
Adopting Red Cotton CRISPR Gene Editing Designer (www.rc-crispr.com), two sgRNAs targeting the ZCCHC12 gene are designed to generate a knockout strategy. The two sgRNA sequences are subsequently cloned into the EZ-editor™ vector and introduced into HEK293-A cells via electroporation or lentiviral transduction. Single-cell clones are then generated using the limiting dilution method. Genomic DNA from individual clones is subjected to nucleic acid lysis and PCR amplification using the EZ-editor™ Monoclone Genotype Validation Kit (Cat# YK-MV-1000). The edited loci are further verified by Sanger sequencing to confirm the genotype. After secondary validation and quality confirmation, ZCCHC12 Knockout cell line (HEK293-A) is expanded and cryopreserved for downstream applications.
KO Cell Construction Strategy

Product Overview

ZCCHC12 Knockout cell line (HEK293-A)
The ZCCHC12 Knockout cell line (HEK293-A) is generated by targeted disruption of the ZCCHC12 gene in HEK293-A cells. This cell line is designed to investigate the role of ZCCHC12 in cellular function and gene regulation, as well as its potential involvement in disease-related pathways.
KO Cell Line
ZCCHC12 Knockout cell line (HEK293-A)
Gene ID
170261
Catalog
YKO-HA240305
Gene Name
ZCCHC12
Product Category
Knockout(KO) Cell Line
Gene Information
NCBI
Species
Human
Mycoplasma test
Negative
Cell Morphology
Epithelial-like, adheren
Catalog Status
-
Culture method
90%DMEM+10%FBS
Shipping
Cryopreserved Cells shipped in dry ice
Passage ratio
1：2-1：4
Storage Condition
Liquid nitrogen
Quality Control
All KO cell products are tested and confirmed to be free of bacterial, viral, mycoplasma contamination, and other adventitious agents.
Applications
For research use only. Not intended for use in diagnostic, therapeutic, clinical, or other applications.

Key Advantages

Easy to use
Easy to use

Cas9 cell lines in our cell bank can stably express Cas9 protein. Each Cas9 Stable Cell Line is easy to use and enables gene knockout simply by transfecting gRNA, while transfection of gRNA and donor DNA results in gene knock-in or point mutations

High-efficient KO
High-efficient KO

These Cas9 stable cell lines have been used to construct the KO cell lines for various genes, gene KO efficiency 5-10 times improved.

Curated cells
Curated cells

Selected cells, low passages, good cell condition, high activity, applicable for all kinds of gene-editing experiments.

Quality Control Specifications

1. Bacteria and Fungi Test
None Detected.
2. Mycoplasma test
Negative.
3. Knockout Strategy

Targeted knockout region: EExon 4

Reference Transcript: NM_173798

Frameshift Mutation Strategy

4. STR Authentication
Download STR Report

Intended use

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use

References

More

FAQ

Q1. How to Contact Support if Issues Arise After Receiving the KO Cells?
If any abnormalities are observed after receiving the cells, please provide the following information based on the stage of use and contact us promptly for assistance:
(1) Issues upon delivery: Please provide photos of the cells at the time of receipt along with a brief description of the issue. We will offer after-sales support accordingly.
(2) Issues after thawing or passaging: Please provide microscopic images of the cells before and after thawing/passaging, along with a detailed description of the experimental procedures. Our technical team will provide professional support.
Q2. What Information Is Required When Reporting KO Cell Product Issues?
Q3. How Should the KO cell Product Be Stored Upon Receipt?
Q4. Shipping Method
Q5. Are the Knockout Cell Lines Stable for Passaging? Is Authentication Provided?

Related Popular Products

KO Cell Lines
ZCCHC12 Knockout cell line (293T)
Organism: Human
Gene Name: ZCCHC12
Gene ID: 170261
Size: 1*10^6
Catalog#: YKO-HT26485
More
ZCCHC12 Knockout cell line (AC16)
Organism: Human
Gene Name: ZCCHC12
Gene ID: 170261
Size: 1*10^6
Catalog#: YKO-HB47811
More
ZCCHC12 Knockout cell line (BEAS-2B)
Organism: Human
Gene Name: ZCCHC12
Gene ID: 170261
Size: 1*10^6
Catalog#: YKO-HB32323
More

Contact Us

Simply fill out the form below to leave your inquiry
— we will respond within 24 Hours.

* Name

* Email

* Institution

* Products & Services of Interest

If email is not available, how else can we reach you?

How did you hear about us?

icon
to-top
Logo
E-mail: info@ubigene.com
WhatsAPP: +86 153 6067 3248
TEL: +86 153 6067 3248(Int'l)
Chat with an Expert
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Copyright © 2025 Ubigene. All rights reserved.
Privacy PolicyImpressum